#VisualAbstract: Pembrolizumab plus cetuximab shows early clinical efficacy for patients with recurrent or metastatic head and neck squamous cell carcinoma
Click to read the study in The Lancet Oncology.
Tag: head and neck cancer
#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer
Click to read the study in the Journal of Clinical Oncology.
#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma
Click to read the study in JAMA Network Open.
#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma
Click to read the study in Clinical Cancer Research.
#VisualAbstract: Risk factors associated with speech and voice impairment in long-term survivors of oropharyngeal cancer
Click to read the study in JAMA Otolaryngology-Head & Neck Surgery.
#VisualAbstract: Docetaxel, cisplatin, and cetuximab regimen is a safe alternative for patients with squamous cell carcinoma of the head and neck
Click to read the study in The Lancet Oncology.
#VisualAbstract: Hyperfractionated radiotherapy with concomitant chemotherapy is highly effective for locally advanced head and neck cancers
Click to read the study in The Lancet Oncology.
#VisualAbstract: Lobaplatin-based induction chemotherapy is safe and efficacious for patients with advanced nasopharyngeal carcinomas
Click to read the study in The Lancet Oncology.
#VisualAbstract: Avelumab does not improve outcomes in patients receiving chemoradiotherapy for squamous cell carcinomas of the head and neck
Click to read the study in The Lancet Oncology.
#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy
Click to read the study in JAMA Surgery.